What is the maximum recommended dose of rizatriptan (Maxalt) in a 24-hour period?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Maximum Recommended Dose of Rizatriptan (Maxalt) in a 24-Hour Period

The maximum daily dose of rizatriptan should not exceed 30 mg in any 24-hour period. 1

Dosing Guidelines for Adults

  • The recommended starting dose of rizatriptan is either 5 mg or 10 mg for the acute treatment of migraines in adults 1
  • If the migraine headache returns, a second dose may be administered 2 hours after the first dose 1
  • The 10 mg dose may provide a greater effect than the 5 mg dose, but may have a greater risk of adverse reactions 1, 2
  • Rizatriptan can be taken every two hours as needed, but should not exceed the maximum daily dose of 30 mg 3, 1

Special Dosing Considerations

Patients Taking Propranolol

  • For adult patients taking propranolol, only the 5 mg dose of rizatriptan is recommended 1
  • The maximum daily dose for patients on propranolol is 15 mg (three 5 mg doses in a 24-hour period) 1
  • This dosage adjustment is necessary due to drug interactions between propranolol and rizatriptan 1

Pediatric Patients

  • For pediatric patients weighing less than 40 kg (88 lb), the recommended dose is 5 mg 1
  • For pediatric patients weighing 40 kg (88 lb) or more, the recommended dose is 10 mg 1
  • The efficacy and safety of treatment with more than one dose of rizatriptan within 24 hours has not been established in pediatric patients 6 to 17 years of age 1

Safety Considerations

  • The safety of treating, on average, more than four headaches in a 30-day period has not been established 1
  • Common adverse effects include dizziness, somnolence, fatigue, chest pressure/tightness, and nausea 1, 2
  • Rizatriptan is contraindicated in patients with:
    • Heart problems or history of heart problems 1
    • History of stroke or transient ischemic attack (TIA) 1
    • Blood vessel problems including ischemic bowel disease 1
    • Uncontrolled hypertension 1
    • Use of other triptan medications within the past 24 hours 1
    • Use of ergot-containing medications within the past 24 hours 1
    • Hemiplegic or basilar migraines 1
    • Use of monoamine oxidase (MAO) inhibitors within the past 2 weeks 1

Clinical Efficacy

  • Rizatriptan has shown greater efficacy than placebo in providing pain relief, pain-free status, relief from associated symptoms, and normal functional ability 2, 4
  • Studies indicate that rizatriptan 10 mg provides faster pain relief and a higher percentage of patients with pain-free status at 2 hours compared to some other triptans 4
  • If one triptan is ineffective for a patient, a different triptan should be tried 3
  • Patients should try a medication for 2-3 headache episodes before abandoning that line of therapy 3

Practical Administration Tips

  • If rizatriptan is ineffective after dose optimization, consider switching to another triptan 5
  • For patients with severe nausea or vomiting, consider using a non-oral triptan formulation 5
  • Rizatriptan is available as both traditional tablets and orally disintegrating tablets (Maxalt MLT) 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Sumatriptan Administration and Efficacy for Migraine Headaches

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.